PRED - Predictive Technology Group, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
2.1350
+0.0350 (+1.67%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close2.1000
Open2.1000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.0850 - 2.1700
52 Week Range0.7700 - 3.0800
Volume223,872
Avg. Volume205,877
Market Cap581.852M
Beta (3Y Monthly)2.60
PE Ratio (TTM)N/A
EPS (TTM)-0.0540
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire23 days ago

    Predictive Technology Group Announces Lab Expansion and New Research and Development Facility for Subsidiary, Predictive Biotech

    SALT LAKE CITY, March 28, 2019 -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent precision.

  • GlobeNewswire25 days ago

    Predictive Technology Group Completes Acquisition of Taueret Laboratories

    Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces it has completed the acquisition of Taueret Laboratories, LLC, a clinical and research molecular laboratory, for $9,747,800, with $1,200,000 paid at closing in the form of the Company’s restricted common stock and $8,547,800 to be paid on or before December 31, 2020, subject to certain conditions. Taueret Laboratories will join Predictive Technology Group’s newest subsidiary Predictive Laboratories. “With the completion of this acquisition and addition of a highly experienced staff, we have formed an unparalleled molecular clinical and research facility to support our objectives of commercializing novel diagnostics based on predictive analytics and extensive genetic information,” said Bradley C. Robinson, CEO of Predictive Technology Group.

  • GlobeNewswirelast month

    Predictive Technology Group Names Senator Orrin G. Hatch and Ronald Barhorst to Its Board of Directors

    Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces the appointment of Senator Orrin G. Hatch and Ronald Barhorst to the company’s Board of Directors, effective immediately. Senator Hatch brings experience from his seven terms as a U.S. Senator including serving as a member and/or chair of various U.S. Senate committees. Mr. Barhorst brings 25 years of experience as a senior executive in the financial services industry and has served as an advisor to the company or its predecessors for nearly 10 years.

  • GlobeNewswirelast month

    Juneau Biosciences Gives Four Presentations at the 66th Annual Meeting of the Society for Reproductive Investigation (SRI)

    Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that Juneau Biosciences is delivering four scientific presentations at the 66th Annual Meeting of the Society for Reproductive Investigation (SRI), which is being held from Tuesday, March 12th to Saturday, March, 16th in Paris, France.  Predictive Technology Group inlicensed the technology supporting its ARTGuide® Test for endometriosis and other genetic causes of infertility from Juneau and is the company’s largest shareholder.

  • GlobeNewswirelast month

    Juneau Biosciences to Present at the 66th Annual Meeting of the Society for Reproductive Investigation (SRI)

    Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that Juneau Biosciences will deliver four scienctific presentations at the 66th Annual Meeting of the Society for Reproductive Investigation (SRI), which will be held from Tuesday, March 12th to Saturday, March, 16th in Paris, France.  Predictive Technology Group inlicensed the technology supporting its ARTGuide® Test for endometriosis and other genetic causes of infertility from Juneau and is the company’s largest shareholder.

  • GlobeNewswire2 months ago

    Predictive Technology Group Sponsors 5th Annual Perinatal Stem Cell Society Congress

    Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that its subsidiary Predictive Biotech sponsored the 5th Annual Perinatal Stem Cell Society Congress held February 28 through March 1, 2019 in Salt Lake City.  Predictive Biotech uses perinatal tissue to produce human cell and tissue products. “We are pleased that Predictive has joined the perinatal society as a platinum sponsor for the second year.

  • GlobeNewswire2 months ago

    Predictive Technology Group Names Jay M. Moyes to Its Board of Directors

    Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that Jay M. Moyes has been named to the company’s Board as an independent director, effective immediately. Moyes brings more than 30 years of healthcare industry expertise in senior-level financial positions and has significant governance experience from Board memberships at publicly traded healthcare companies. “We are delighted to attract a professional of Jay’s caliber as we build out Predictive’s Board with proven leaders to support our strategy of bringing proprietary genetic-based diagnostics and therapeutics to market,” said Bradley C. Robinson, CEO of Predictive Technology Group.

  • GlobeNewswire2 months ago

    Predictive Technology Group Reports Second Quarter Fiscal 2019 Financial

    SALT LAKE CITY, Feb. 15, 2019 -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic.

  • GlobeNewswire5 months ago

    Predictive Technology Group to Present at 11th Annual LD Micro Main Event Conference on December 4

    SALT LAKE CITY, Nov. 27, 2018 -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a life-sciences technology company, announces that Bradley Robinson, President and CEO,.

  • GlobeNewswire6 months ago

    Predictive Technology Group Appoints Industry Veteran John E. Sorrentino as Chairman

    Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through precision therapeutic treatments, announces that John E. Sorrentino has been named Chairman of the Board in addition to his role as Chair of the Predictive Scientific Advisory Board. Sorrentino has more than 35 years of senior management experience in the life sciences industry and serves as Vice President and Chief Operating Officer of Pfizer Vaccine Research and Development.

  • Zacks Small Cap Research7 months ago

    PRED: Early Diagnosis Can Save 1 in 10 Women

    Endometriosis affects an estimated 200 million women worldwide and is frequently misdiagnosed, preventing its early and proper treatment. Failing to properly identify and treat endometriosis typically results in irreversible periodic intense pain, infertility, bowel and urinary disorders and other discomfort. As of today, there are no lab tests available to diagnose endometriosis.